| Antonio Mora Alandy, MD | |
|
200 J Ave Ste A, Eureka, SD 57437-2225 | |
| (605) 284-2621 | |
| (605) 284-2623 |
| Full Name | Antonio Mora Alandy |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 200 J Ave Ste A, Eureka, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083624241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 3430 (South Dakota) | Primary |
| Entity Name | Eureka Community & Benevolent Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881047371 PECOS PAC ID: 5698711653 Enrollment ID: O20160825002692 |
News Archive
What do obesity, heart disease, depression, diabetes, and fibromyalgia have in common? The answer is vitamin D deficiency. More than 200 million Americans lack this essential vitamin and as a result suffer from a host of daily annoyances, chronic conditions, and even life-threatening illnesses.
Aiming to relaunch the nation's patient safety agenda with renewed energy and focus, the Institute for Healthcare Improvement today hosts representatives from 24 organizations to begin work on a national strategy for reducing harm in the delivery of health care.
GVK Biosciences, Asia's leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.
Although informed consent is an ethical cornerstone in research with humans, some studies suggests that volunteers often do not understand key aspects of the research in which they participate. Recent efforts have been made to improve informed consent by simplifying the consent forms.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Antonio Mora Alandy, MD Po Box 37, Eureka, SD 57437-0037 Ph: (605) 284-2342 | Antonio Mora Alandy, MD 200 J Ave Ste A, Eureka, SD 57437-2225 Ph: (605) 284-2621 |
News Archive
What do obesity, heart disease, depression, diabetes, and fibromyalgia have in common? The answer is vitamin D deficiency. More than 200 million Americans lack this essential vitamin and as a result suffer from a host of daily annoyances, chronic conditions, and even life-threatening illnesses.
Aiming to relaunch the nation's patient safety agenda with renewed energy and focus, the Institute for Healthcare Improvement today hosts representatives from 24 organizations to begin work on a national strategy for reducing harm in the delivery of health care.
GVK Biosciences, Asia's leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.
Although informed consent is an ethical cornerstone in research with humans, some studies suggests that volunteers often do not understand key aspects of the research in which they participate. Recent efforts have been made to improve informed consent by simplifying the consent forms.
› Verified 7 days ago